✦ LIBER ✦

Long-term survival advantage of intraperitoneal chemotherapy treatment in advanced ovarian cancer: An analysis of a Gynecologic Oncology Group ancillary data study

✍ Scribed by Tewari, D.; Java, J.; Salani, R.; Armstrong, D.; Markman, M.; Herzog, T.; Monk, B.; Chan, J.

Book ID: 123330131
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 130
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.04.065

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy-induced neutropenia as a bi

Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: An exploratory study of the Gynecologic Oncology Group

✍ Tewari, Krishnansu S.; Java, James J.; Gatcliffe, Troy A.; Bookman, Michael A.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Patterns of crossover to antiangiogenesi

Patterns of crossover to antiangiogenesis agents in recurrent ovarian cancer patients: An analysis of a Gynecologic Oncology Group ancillary data study (GOG#218, abstract)

✍ Chan, J.; Java, J.; Monk, B.; Coleman, R.; Birrer, M.; Aghajanian, C.; Bookman, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Negative survival impact associated with

Negative survival impact associated with >25 day interval from surgical cytoreduction to initiation of systemic therapy in advanced ovarian carci- noma: A Gynecologic Oncology Group ancillary data study

✍ Eskander, R.; Java, J.; Tewari, K.; Burger, R.; Monk, B. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 291 KB

CA-125 change after chemotherapy in pred

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers : A Gynecologic Oncology Group study

✍ Chunqiao Tian; Maurie Markman; Richard Zaino; Robert F. Ozols; William P. McGuir 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Does maintaining adjuvant chemotherapy d

Does maintaining adjuvant chemotherapy dose intensity have an impact on the outcome of treatment in ovarian cancer patients?: A Gynecologic Oncology Group study

✍ A. Olawaiye; J. Java; T. Krivak; M. Bookman; T. Herzog 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A Gynecologic Oncology Group Study of se

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

✍ Thomas C. Krivak; Chunqiao Tian; G. Scott Rose; Deborah K. Armstrong; G. Larry M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 318 KB